📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Carbylan

1.1 - Company Overview

Carbylan Logo

Carbylan

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of products and services; specific offerings not available. Founded in 2004.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Carbylan

Acticor Biotech Logo

Acticor Biotech

HQ: France Website
  • Description: Provider of biopharmaceutical development of glenzocimab, a humanized monoclonal antibody fragment targeting platelet GPVI with antithrombotic properties without increasing bleeding risk, for the acute phase of ischemic stroke. Runs clinical trials: ACTISAVE, ACTIMIS, and GREEN in stroke, LIBERATE in myocardial infarction, and GARDEN in SARS-CoV-2-related ARDS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acticor Biotech company profile →
Prestwick Pharmaceuticals Logo

Prestwick Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutic pharmaceutical drugs for chronic central nervous system diseases, offering products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea. Founded in 2002 and based in Washington, District of Columbia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prestwick Pharmaceuticals company profile →
Ad-Tech Medical Logo

Ad-Tech Medical

HQ: United States Website
  • Description: Provider of intra-cranial monitoring devices (electrodes) for the treatment of intractable epilepsy and neurosurgical instrumentation. Offerings include depth, subdural grid and strip, and foramen ovale electrodes for long-term EEG monitoring, mapping, SEEG, and intraoperative use; placement instruments and accessories for precise electrode placement; and connection systems to link electrodes to standard clinic EEG equipment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ad-Tech Medical company profile →
SwanBio Therapeutics Logo

SwanBio Therapeutics

HQ: United States Website
  • Description: Provider of gene therapy focused on genetically defined therapies for neurological disorders. Offerings include SBT101, a candidate for adrenomyeloneuropathy targeting ABCD1 via AAV9; pipeline development in spinal cord-related indications; clinical trials, including a Phase 1/2 study of SBT101 and natural history studies of AMN; and patient and family resources, including trial information and compassionate use policies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SwanBio Therapeutics company profile →
Cantabio Pharmaceuticals Logo

Cantabio Pharmaceuticals

HQ: United States Website
  • Description: Provider of preclinical biotechnology drug discovery research and therapeutic development focused on neurodegenerative and metabolic diseases, developing small-molecule DJ-1 protein-targeting therapeutics for Parkinson’s and other conditions and Tau protein-targeting therapeutics for Alzheimer’s and related tauopathies, integrating biophysics and novel technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cantabio Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Carbylan

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Carbylan

2.2 - Growth funds investing in similar companies to Carbylan

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Carbylan

4.2 - Public trading comparable groups for Carbylan

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Carbylan

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Carbylan

What does Carbylan do?

Carbylan is a provider of products and services; specific offerings not available. Founded in 2004.

Who are Carbylan's competitors?

Carbylan's competitors and similar companies include Acticor Biotech, Prestwick Pharmaceuticals, Ad-Tech Medical, SwanBio Therapeutics, and Cantabio Pharmaceuticals.

Where is Carbylan headquartered?

Carbylan is headquartered in United States.

How many employees does Carbylan have?

Carbylan has 1,000 employees 🔒.

When was Carbylan founded?

Carbylan was founded in 2010 🔒.

What sector and industry vertical is Carbylan in?

Carbylan is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Carbylan

Who are the top strategic acquirers in Carbylan's sector and industry

Top strategic M&A buyers and acquirers in Carbylan's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Carbylan?

Top strategic M&A buyers groups and sectors for Carbylan include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Carbylan's sector and industry vertical

Which are the top PE firms investing in Carbylan's sector and industry vertical?

Top PE firms investing in Carbylan's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Carbylan's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Carbylan's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Carbylan's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Carbylan include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Carbylan's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Carbylan?

The key public trading comparables and valuation benchmarks for Carbylan include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Carbylan for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Carbylan with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Carbylan's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Carbylan with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Carbylan's' sector and industry vertical?

Access recent funding rounds and capital raises in Carbylan's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Carbylan